Pfütze, K., Yang, R., Bläker, H., Herpel, E., Ulrich, A., Brenner, H., & Burwinkel, B. (2015). Methylation status at HYAL2 predicts overall and progression-free survival of colon cancer patients under 5-FU chemotherapy. Genomics, 106(6), . https://doi.org/10.1016/j.ygeno.2015.10.002
Chicago-Zitierstil (17. Ausg.)Pfütze, Katrin, Rongxi Yang, Hendrik Bläker, Esther Herpel, Alexis Ulrich, Hermann Brenner, und Barbara Burwinkel. "Methylation Status at HYAL2 Predicts Overall and Progression-free Survival of Colon Cancer Patients Under 5-FU Chemotherapy." Genomics 106, no. 6 (2015). https://doi.org/10.1016/j.ygeno.2015.10.002.
MLA-Zitierstil (9. Ausg.)Pfütze, Katrin, et al. "Methylation Status at HYAL2 Predicts Overall and Progression-free Survival of Colon Cancer Patients Under 5-FU Chemotherapy." Genomics, vol. 106, no. 6, 2015, https://doi.org/10.1016/j.ygeno.2015.10.002.